Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VTGN | AMGN | BMY | VRTX | GILD |
| Company | Vistagen Therapeutics Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 2.71 | 275.81 | 58.57 | 454.72 | 92.59 |
| High | 2.75 | 278.55 | 58.79 | 462.02 | 92.60 |
| Low | 2.64 | 273.86 | 57.59 | 450.00 | 89.86 |
| Last | 2.65 | 278.27 | 58.37 | 459.00 | 91.62 |
| Change | -0.05 | -0.05 | -0.32 | +2.03 | -0.87 |
| % Change | -1.85% | -0.02% | -0.55% | +0.44% | -0.94% |
| Volume | 151,073 | 1,851,772 | 4,410,838 | 615,458 | 3,779,966 |
| 20-Day Average Volume | 222,778 | 4,437,238 | 11,248,949 | 1,361,591 | 7,350,723 |
| Previous Close | 2.70 | 278.32 | 58.69 | 456.97 | 92.49 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.78 | 293.66 | 57.95 | 473.01 | 92.01 |
| 20-Day Raw Stochastic | 23.84% | 29.08% | 61.46% | 19.62% | 42.04% |
| 20-Day Relative Strength | 41.90% | 33.91% | 57.93% | 45.26% | 55.03% |
| Weighted Alpha | -49.11 | -4.56 | +24.72 | +21.59 | +24.55 |
| Today's Opinion | 100% Sell | 72% Sell | 100% Buy | 8% Sell | 88% Buy |
| Previous Opinion | 100% Sell | 72% Sell | 100% Buy | 8% Sell | 100% Buy |
| Last Month's Opinion | 64% Sell | 8% Buy | 88% Buy | 24% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.31% since 11/26/24 | -0.61% since 11/26/24 | -0.68% since 11/26/24 | -1.58% since 11/26/24 | +0.13% since 11/26/24 |
| Low | 2.58 on 11/27/24 | 273.86 on 12/04/24 | 57.59 on 12/04/24 | 451.05 on 12/04/24 | 89.86 on 12/04/24 |
| High | 2.90 on 12/02/24 | 283.64 on 11/29/24 | 60.09 on 12/03/24 | 470.93 on 11/29/24 | 94.39 on 12/03/24 |
| 1-Month | |||||
| %Chg | -17.39% since 11/04/24 | -12.19% since 11/04/24 | +5.21% since 11/04/24 | -2.77% since 11/04/24 | +1.81% since 11/04/24 |
| Low | 2.48 on 11/22/24 | 257.80 on 11/26/24 | 53.97 on 11/08/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 3.25 on 11/05/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -18.40% since 09/04/24 | -15.83% since 09/04/24 | +16.77% since 09/04/24 | -3.95% since 09/04/24 | +15.59% since 09/04/24 |
| Low | 2.48 on 11/22/24 | 257.80 on 11/26/24 | 47.55 on 09/09/24 | 445.00 on 11/21/24 | 77.74 on 09/05/24 |
| High | 3.44 on 09/09/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -32.49% since 06/04/24 | -9.46% since 06/04/24 | +39.74% since 06/04/24 | -3.21% since 06/04/24 | +42.57% since 06/04/24 |
| Low | 2.48 on 11/22/24 | 257.80 on 11/26/24 | 39.35 on 07/05/24 | 445.00 on 11/21/24 | 62.69 on 06/18/24 |
| High | 4.21 on 07/11/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 75,176 | 149,606,192 | 119,033,712 | 117,683,024 | 115,267,136 |
| Shares Outstanding, K | 27,843 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 1,060,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -29,360,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 180,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -12,960,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.82 | 0.55 | 0.45 | 0.36 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.42 on 11/07/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/07/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.47 | 51.23 | 0.00 | 21.22 |